July 13, 2017 - By Max Morgan <\/p>\n
Edgewood Management Llc increased its stake in Celgene Corp (CELG) by 0.56% based on its latest 2016Q4 regulatory filing with the SEC. Edgewood Management Llc bought 53,467 shares as the companys stock declined 3.49% while stock markets rallied. The institutional investor held 9.59M shares of the major pharmaceuticals company at the end of 2016Q4, valued at $1.11B, up from 9.54M at the end of the previous reported quarter. Edgewood Management Llc who had been investing in Celgene Corp for a number of months, seems to be bullish on the $106.16 billion market cap company. The stock rose 0.79% or $1.06 reaching $134.62 per share. About 3.78 million shares traded. Celgene Corporation (NASDAQ:CELG) has risen 17.00% since July 13, 2016 and is uptrending. It has outperformed by 0.30% the S&P500. <\/p>\n
Hal Mintz decreased its stake in Edap Tms S A (EDAP) by 95.79% based on its latest 2016Q4 regulatory filing with the SEC. Sabby Management Llc sold 522,925 shares as the companys stock declined 9.68% while stock markets rallied. The hedge fund run by Hal Mintz held 22,993 shares of the electromedical & electrotherapeutic apparatus company at the end of 2016Q4, valued at $76,000, down from 545,918 at the end of the previous reported quarter. Sabby Management Llc who had been investing in Edap Tms S A for a number of months, seems to be less bullish one the $93.27 million market cap company. The stock rose 1.26% or $0.04 reaching $3.22. About 75,787 shares traded. Edap Tms SA (ADR) (NASDAQ:EDAP) has declined 15.92% since July 13, 2016 and is downtrending. It has underperformed by 32.62% the S&P500. <\/p>\n
More recent Edap Tms SA (ADR) (NASDAQ:EDAP) news were published by: Benzinga.com which released: 20 Stocks Moving In Wednesdays Pre-Market Session on June 21, 2017. Also Benzinga.com published the news titled: Earnings Scheduled For April 3, 2017 on April 03, 2017. Quotes.Wsj.coms news article titled: EDAP TMS SA ADR with publication date: February 11, 2011 was also an interesting one. <\/p>\n
Sabby Management Llc, which manages about $835.79M and $1.72B US Long portfolio, upped its stake in Spdr S&P Biotech Etf (Put) by 2,665 shares to 4,623 shares, valued at $27.36M in 2016Q4, according to the filing. It also increased its holding in Fibrogen Inc (Call) by 1,025 shares in the quarter, for a total of 1,189 shares, and has risen its stake in Aeterna Zentaris Inc. <\/p>\n
Edgewood Management Llc, which manages about $9.25B and $15.20 billion US Long portfolio, decreased its stake in American Tower Corp New (NYSE:AMT) by 490,202 shares to 5.77M shares, valued at $610.23 million in 2016Q4, according to the filing. It also reduced its holding in Alexion Pharmaceuticals Inc (NASDAQ:ALXN) by 4,660 shares in the quarter, leaving it with 5,295 shares, and cut its stake in Ishares Tr (DVY). <\/p>\n
Investors sentiment decreased to 0.98 in Q4 2016. Its down 0.13, from 1.11 in 2016Q3. It turned negative, as 57 investors sold CELG shares while 470 reduced holdings. 116 funds opened positions while 398 raised stakes. 587.86 million shares or 1.69% more from 578.10 million shares in 2016Q3 were reported. Asset Mngmt One has 1.35M shares for 0.39% of their portfolio. Hanson Mcclain Inc holds 0% or 248 shares. Moreover, Cypress Asset Management Tx has 0.31% invested in Celgene Corporation (NASDAQ:CELG). Family, a New York-based fund reported 15,324 shares. Martingale Asset Limited Partnership holds 0.11% or 69,477 shares. First Allied Advisory stated it has 82,123 shares. Crestwood Advisors Ltd reported 2,415 shares. Selkirk Ltd Llc reported 248,250 shares stake. Cobblestone Capital Advisors Ny holds 0.28% or 17,675 shares in its portfolio. Tfs Lc stated it has 3,856 shares. 36,002 were reported by Chase Invest Counsel. Sun Life stated it has 0% in Celgene Corporation (NASDAQ:CELG). First Mercantile Trust has invested 0.83% in Celgene Corporation (NASDAQ:CELG). Marietta Invest Ptnrs Limited Liability Corporation accumulated 47,828 shares or 1.95% of the stock. Denver Advsr Limited Liability Com has 0.08% invested in Celgene Corporation (NASDAQ:CELG). <\/p>\n
Among 23 analysts covering Celgene Corporation (NASDAQ:CELG), 18 have Buy rating, 0 Sell and 5 Hold. Therefore 78% are positive. Celgene Corporation had 53 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has Buy rating by Mizuho given on Thursday, June 1. The rating was initiated by Raymond James on Tuesday, September 1 with Strong-Buy. The rating was maintained by Cantor Fitzgerald on Thursday, July 6 with Buy. BTIG Research upgraded Celgene Corporation (NASDAQ:CELG) on Thursday, August 4 to Buy rating. On Friday, June 23 the stock rating was maintained by Jefferies with Buy. Cowen & Co maintained the shares of CELG in report on Wednesday, August 12 with Outperform rating. The firm has Outperform rating given on Friday, January 29 by RBC Capital Markets. The firm has Outperform rating given on Tuesday, April 19 by Credit Suisse. The firm has Buy rating by SunTrust given on Thursday, January 7. Stifel Nicolaus initiated Celgene Corporation (NASDAQ:CELG) on Friday, July 15 with Buy rating. <\/p>\n
More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Fool.com which released: Can Celgene Corporation Be a Value Stock? on June 15, 2017, also Businesswire.com with their article: Celgene Corporation Enters Into Global Strategic Immuno-Oncology Collaboration published on July 06, 2017, Fool.com published: Better Buy: Amgen Inc. vs. Celgene Corporation on July 08, 2017. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Fool.com and their article: Why Celgene Corporation Stock Bolted Higher in June published on July 11, 2017 as well as Nasdaq.coms news article titled: Portland Global Advisors LLC Buys Celgene Corp, Sells Mobileye NV, The Kroger Co with publication date: July 12, 2017. <\/p>\n
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter. <\/p>\n
<\/p>\n
The rest is here:<\/p>\n
Edap Tms SA (EDAP) Shareholder Sabby Management Lowered Its Position by $1.57 Million; Edgewood Management ... - BZ Weekly<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" July 13, 2017 - By Max Morgan Edgewood Management Llc increased its stake in Celgene Corp (CELG) by 0.56% based on its latest 2016Q4 regulatory filing with the SEC. Edgewood Management Llc bought 53,467 shares as the companys stock declined 3.49% while stock markets rallied. Continue reading